Sidra Medicine to Expand Pediatric Therapy Capabilities with New Sensory Integration Gym
28 April, 2026
Sidra Medicine to Expand Pediatric Therapy Capabilities with New Sensory Integration Gym

Sidra Medicine, is developing a new Sensory Integration Gym as part of its continued expansion of specialized pediatric rehabilitation services. The gym will provide an advanced therapeutic environment for children with neurodevelopmental, behavioral, and sensory processing challenges.
Read more
Sidra Medicine introduces Qatar’s first advanced gene-editing therapy for sickle cell disease and thalassemia
21 April, 2026
Sidra Medicine introduces Qatar’s first advanced gene-editing therapy for sickle cell disease and thalassemia

Sidra Medicine, a member of Qatar Foundation, has been qualified by Vertex Pharmaceuticals as one of a of a limited number of hospitals in the world, to administer Casgevy, a groundbreaking, one-time CRISPR/Cas9-based gene therapy treatment.
Read more
Sidra Medicine Performs Qatar’s First Pediatric Sacral Neuromodulation
15 April, 2026
Sidra Medicine Performs Qatar’s First Pediatric Sacral Neuromodulation

Sidra Medicine, has successfully performed a sacral neuromodulation implantation procedure on an eight-year-old child with spina bfida.
Read more
Sidra Medicine Highlights Advances to  Family-Centered Care to Mark World Health Day 2026
7 April, 2026
Sidra Medicine Highlights Advances to  Family-Centered Care to Mark World Health Day 2026

To mark World Health Day on April 7,  Sidra Medicine reinforces its role as a research-driven, patient-centered healthcare organization by announcing its latest service launches and expansion plans for 2026.
Read more
Sidra Medicine Treats 10th Patient with Duchenne Muscular Dystrophy
31 March, 2026
Sidra Medicine Treats 10th Patient with Duchenne Muscular Dystrophy

Sidra Medicine, a member of Qatar Foundation, has provided specialized treatment to a child from Egypt diagnosed with Duchenne Muscular Dystrophy (DMD).
Read more
Sidra Medicine Highlights Precision Medicine Breakthrough for Rare Genetic Condition
28 February, 2026
Sidra Medicine Highlights Precision Medicine Breakthrough for Rare Genetic Condition

Sidra Medicine, Qatar’s specialist women’s and children’s hospital and a member of Qatar Foundation, has highlighted the real-world impact of precision medicine on a six year old patient with a rare genetic condition.
Read more
Sidra Medicine and QatarEnergy Sign Memorandum of Understanding
24 February, 2026
Sidra Medicine and QatarEnergy Sign Memorandum of Understanding

Sidra Medicine and QatarEnergy have signed a Memorandum of Understanding (MoU) to set a framework for mutual collaboration across healthcare services, professional development opportunities, and the exchange of expertise.
Read more
Sidra Medicine Sets a New Benchmark as Only Organisation in Middle East and Europe to Reach HIMSS DIAM Stage 6
11 February, 2026
Sidra Medicine Sets a New Benchmark as Only Organisation in Middle East and Europe to Reach HIMSS DIAM Stage 6

Sidra Medicine, a member of Qatar Foundation, has reached a significant milestone in its digital transformation journey, with formal validation of achieving Stage 6 in both HIMSS EMRAM and HIMSS DIAM.
Read more
Sidra Medicine Signs MoU with Builders VC MENA to Advance Healthcare Innovation
4 February, 2026
Sidra Medicine Signs MoU with Builders VC MENA to Advance Healthcare Innovation

The MoU is aimed at strengthening collaboration in healthcare innovation, supporting the development of emerging medical technologies, and expanding partnership opportunities between medical research ecosystems and healthcare-focused venture investment.
Read more

Our Insurance Partners

Our Insurance Partners